[1]肖叔敏 叶翠 周赛君 于珮.NK细胞数量在2型糖尿病患者外周血中的 变化及临床意义[J].国际内分泌代谢杂志,2019,39(03):145-150.[doi:10.3760/cma.j.issn.1673-4157.2019.03.001]
 Xiao Shumin,Ye Cui,Zhou Saijun,et al.Changes of the number of NK cells in peripheral blood of patients with type 2 diabetes mellitus and its clinical significance[J].International Journal of Endocrinology and Metabolism,2019,39(03):145-150.[doi:10.3760/cma.j.issn.1673-4157.2019.03.001]
点击复制

NK细胞数量在2型糖尿病患者外周血中的 变化及临床意义()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
39
期数:
2019年03期
页码:
145-150
栏目:
论著
出版日期:
2019-05-20

文章信息/Info

Title:
Changes of the number of NK cells in peripheral blood of patients with type 2 diabetes mellitus and its clinical significance
作者:
肖叔敏 叶翠 周赛君 于珮
天津医科大学代谢病医院肾病透析科,国家卫生健康委员会激素与发育重点实验室(天津医科大学),天津市代谢性疾病重点实验室,天津医科大学代谢病医院内分泌研究所 300070
Author(s):
Xiao Shumin Ye Cui Zhou Saijun Yu Pei
Department of Nephrology and Dialysis, NHC Key Laboratory of Hormones and Development(Tianjin Medical University), Tianjin Key Laboratory of Metabolic Diseases, The Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300070, China
关键词:
NK细胞 2型糖尿病 免疫炎症 心血管并发症
Keywords:
Natural killer cells Type 2 diabetes mellitus Immune inflammation Cardiovascular complications
DOI:
10.3760/cma.j.issn.1673-4157.2019.03.001
摘要:
目的 观察2型糖尿病(T2DM)患者不同情况下外周血中自然杀伤细胞(NK细胞)及自然杀伤T细胞(NKT细胞)的数量变化,分析其与T2DM心血管并发症的关系。方法 纳入2015年6月—2016年2月于天津医科大学代谢病医院住院治疗的T2DM患者124例(T2DM组)和年龄、性别相匹配的天津医科大学总医院空港医院的健康体检者50名(NC组),于清晨空腹抽取外周静脉血,流式细胞仪检测T2DM组及NC组外周血中NK细胞数量和NKT细胞数量,并按照病程长短及是否合并心血管并发症分亚组,分别观察NK细胞数量和NKT细胞数量在T2DM不同病程、有无心血管并发症存在时的变化。结果 T2DM组NK细胞数量及NKT细胞数量较NC组明显下降(t=4.63、5.38,P均<0.01)。T2DM患者外周血中NK细胞数量与年龄和病程呈负相关(r=-0.36、-0.38,P均<0.05),病程>8年组NK细胞数量较病程≤8年组明显降低(F=20.15,P<0.01)。NKT细胞数量与年龄、稳态模型评估-胰岛素抵抗指数、甘油三酯、极低密度脂蛋白-胆固醇呈负相关(r=-0.20、-0.49、-0.29、-0.28,P均<0.05),与高密度脂蛋白-胆固醇、估算的肾小球滤过率呈正相关(r=0.18、0.22,P均<0.05)。T2DM伴冠心病组NKT细胞数量较T2DM不伴冠心病组有下降趋势(F=20.37,P<0.05),而NK细胞数量较T2DM不伴冠心病组明显下降(F=33.90,P<0.01)。NK细胞监测T2DM伴冠心病患者的受试者工作特征(ROC)曲线下面积为0.92,95%CI为0.84~0.99,敏感性90.9%,特异性80.5%。结论 T2DM患者外周血中NK细胞及NKT细胞数量下降,NK细胞数量对T2DM心血管并发症有监测价值。
Abstract:
Objective To investigate the changes of the number of natural killer cells(NK cells)and natural killer T cells(NKT cells)in peripheral blood in patients with type 2 diabetes mellitus(T2DM)under different conditions, and to analyze their relationship with cardiovascular complications of T2DM.Methods From June 2015 to February 2016, 124 T2DM patients(T2DM group)who were hospitalized in the Metabolic Diseases Hospital of Tianjin Medical University were included and 50 healthy subjects(NC group)matching with age and gender in the Airport Hospital of Tianjin Medical University General Hospital were included. Fasting peripheral venous blood was extracted. The number of NK cells and NKT cells in peripheral blood of T2DM group and NC group were detected by flow cytometry. All patients were then further divided into subgroups according to their diabetic duration and with or without cardiovascular diseases. The changes in the number of NK cells and NKT cells in T2DM with different disease course and with or without cardiovascular complications were observed.Results The number of NK cells and NKT cells in T2DM group were decreased significantly compared with NC group(t=4.63, 5.38, all P<0.01). The number of NK cells in peripheral blood of T2DM patients was negatively correlated with age and disease course(r=-0.36, -0.38, all P<0.05). The number of NK cells in the group with a disease course greater than 8 years was significantly lower than that in the group with a disease course less than or equal to 8 years(F=20.15, P<0.01). The number of NKT cells was negatively correlated with age, homeostasis model assessment of insulin resistance, triglyceride and very low density lipoprotein cholesterol level(r=-0.20, -0.49, -0.29, -0.28, all P<0.05), and positively correlated with the level of high density lipoprotein cholesterol and estimated glomerular filtration rate(r=0.18, 0.22, all P<0.05). In T2DM with coronary heart disease(CHD)group, the number of NKT cells was lower than that in T2DM without CHD group(F=20.37, P<0.05), while the number of NK cells was significantly lower than that in T2DM without CHD group(F=33.90, P<0.01). The area under the receiver operating characteristics(ROC)curve of NK cells predicting T2DM patients with CHD was 0.92(95%CI: 0.84-0.99)with 90.9% sensitivity and 80.5% specificity.Conclusion The number of NK cells and NKT cells in peripheral blood in patients with T2DM are decreased, and the number of NK cells is of monitoring value for cardiovascular complications of T2DM.

参考文献/References:

[1] Haddad JA, Haddad AN. The past decade in type 2 diabetes and future challenges[J]. Hormones(Athens),2018,17(4):451-459. DOI:10.1007/s42000-018-0080-y.
[2] Webb D,Dales J,Zaccardi F,et al.Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5-year and longer-term modelled outcomes of the ADDITION-Leicester study[J].Diabetes Metab Res Rev,2019,35(3):e3111.DOI:10.1002/dmrr.3111.
[3] Szpigel A,Hainault I,Carlier A,et al.Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes[J].Diabetologia,2018,61(2):399-412.DOI:10.1007/s00125-017-4462-5.
[4] Bunting MD,Varelias A,Souza-Fonseca-Guimaraes F,et al.GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity[J].Blood,2017,129(5):630-642.DOI:10.1182/blood-2016-08-734020.
[5] Presta I,Vismara M,Novellino F,et al.Innate immunity cells and the neurovascular unit[J].Int J Mol Sci,2018,19(12):Pii:E3856. DOI:10.3390/ijms19123856.
[6] Phoksawat W,Jumnainsong A,Leelayuwat N,et al.Aberrant NKG2D expression with IL-17 production of CD4+ T subsets in patients with type 2 diabetes[J].Immunobiology,2017,222(10):944-951.DOI:10.1016/j.imbio.2016.05.001.
[7] Nam HW,Cho YJ,Lim JA,et al.Functional status of immune cells in patients with long-lasting type 2 diabetes mellitus[J].Clin Exp Immunol,2018,194(1):125-136.DOI:10.1111/cei.13187.
[8] Bessac A,Cani PD,Meunier E,et al.Inflammation and gut-brain axis during type 2 diabetes: focus on the crosstalk between intestinal immune cells and enteric nervous system[J].Front Neurosci,2018,12:725.DOI:10.3389/fnins.2018.00725.
[9] Schloot NC,Pham MN,Hawa MI,et al.Inverse relationship between organ-specific autoantibodies and systemic immune mediators in type 1 diabetes and type 2 diabetes: action LADA 11[J].Diabetes Care,2016,39(11):1932-1939.DOI:10.2337/dc16-0293.
[10] Domínguez-Andrés J,Feo-Lucas L,Minguito de la Escalera M,et al. Inflammatory Ly6Chigh monocytes protect against candidiasis through IL-15-driven NK cell/neutrophil activation[J].Immunity,2017,46(6):1059-1072.e4.DOI:10.1016/j.immuni.2017.05.009.
[11] Guo H,Xu B,Gao L,et al.High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus[J].Exp Biol Med(Maywood),2012,237(5):556-562.DOI:10.1258/ebm.2012.011272.
[12] Pitkiewicz P,Miek T,Bernat-Karpińska M,et al.The dysfunction of NK cells in patients with type 2 diabetes and colon cancer[J].Arch Immunol Ther Exp(Warsz),2013,61(3):245-253.DOI:10.1007/s00005-013-0222-5.
[13] Xu H,Wang X,Wang W.Monomethylarsonous acid: induction of DNA damage and oxidative stress in mouse natural killer cells at environmentally-relevant concentrations[J].Mutat Res,2018,(832-833):1-6.DOI:10.1016/j.mrgentox.2018.05.017.
[14] Rabacal W,Pabbisetty SK,Hoek KL,et al. Transcription factor KLF2 regulates homeostatic NK cell proliferation and survival[J].Proc Natl Acad Sci U S A,2016,113(19):5370-5375.DOI:10.1073/pnas.1521491113.
[15] Cheng F,Twardowski L,Reifenberg K,et al.Combined B, T and NK cell deficiency accelerates atherosclerosis in BALB/c mice[J].PLoS One,2016,11(8):e0157311.DOI:10.1371/journal.pone.0157311.
[16] Kyaw T,Tipping P,Toh BH,et al.Killer cells in atherosclerosis[J].Eur J Pharmacol,2017,816:67-75.DOI:10.1016/j.ejphar.2017.05.009.
[17] van Puijvelde GHM,Kuiper J.NKT cells in cardiovascular diseases[J].Eur J Pharmacol,2017,816:47-57.DOI:10.1016/j.ejphar.2017.03.052.

相似文献/References:

[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
 Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(03):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
 Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(03):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
 Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
 Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(03):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
 Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(03):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性 血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
 Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(03):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白 与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
 Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平 及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
 Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(03):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
 Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(03):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病 患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
 Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(03):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]

备注/Memo

备注/Memo:
通信作者:于珮,Email:yupei@tijmu.edu.cn
基金项目:国家自然科学基金青年项目(81600643); 天津市自然科学基金面上项目(17JCYBJC27000); 天津市自然科学基金重点项目(18JCZDJC32900)
Corresponding author: Yu Pei, Email: yupei@tijmu.edu.cn
Fund program:National Natural Science Foundation for Young Scientists of China(81600643); Tianjin Natural Science Foundation of China(17JCYBJC2700); Tianjin Natural Science Foundation of China(18JCZDJC32900)
更新日期/Last Update: 2019-05-20